Nanoform launches next-generation STARMAP® v2.0, the AI-based drug candidate selection tool for CESS®

Corporate Breaking News

Home : Nanoform launches next-generation STARMAP® v2.0, the AI-based drug candidate selection tool for CESS®

Mar 22 2021	Nanoform launches next-generation STARMAP® v2.0, the AI-based drug candidate selection tool for CESS®
HELSINKI, March 22, 2021 /PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, has today launched the next generation of its STARMAP® AI (artificial intelligence) platform, v2.0. The technology utilizes sparse-data AI to augment experimental results...


Source:https://www.prnewswire.com:443/news-releases/nanoform-launches-next-generation-starmap-v2-0--the-ai-based-drug-candidate-selection-tool-for-cess-301252665.html

Related News
» International food and beverage corporation Strauss Group wraps up a successful 2020 with 4.6% organic growth[1], recording an increase in local currency sales across geographies in most categories » Zalando Launches Spring Campaign to Laud Society's Champions & Celebrate Their Values